Table 1.
Participants’ characteristics.
| United States | Spain | China | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type of Cohort | CD | UC | Non-IBD | Total | CD | UC | Non-IBD | Total | CD | UC | Non-IBD | Total |
| Number of subjects | 37 | 22 | 20 | 79 | 33 | 33 | 67 | 133 | 62 | NA | 52 | 114 |
| Number of samples | 506 | 319 | 342 | 1167 | 57 | 65 | 67 | 189 | 62 | NA | 52 | 114 |
|
CD location (n)
L1/L1+L4 L2/L2+L4 L3/L3+L4 |
109/45 58/23 128/143 |
NA | NA | NA |
18/2 0/0 35/2 |
NA | NA | NA | NA | NA | NA | NA |
| Gender (% female) | 39.3 | 65.8 | 50.9 | 50.0 | 66.7 | 72.3 | 56.7 | 65.1 | 25.8 | NA | 5.8 | 5.8 |
| Age (mean ± SD) | 22.5 ± 14.2 | 29.2 ± 19.5 | 27.5 ± 19.5 | 27.1 ± 17.7 | 35.8 ± 11.8 | 40.1 ± 10.5 | 43.1 ± 15.9 | 27.5±16.9 | 28.4 ± 8.1 | NA | 20.5 ± 7.8 | 20.5 ± 7.8 |
| BMI (mean ± SD) | 23.3 ± 7.5 | 23.0 ± 6.8 | 23.4 ± 7.0 | 23.3 ± 6.8 | 22.4 ± 4.0 | 23.6 ± 4.1 | 25.0 ± 4.3 | 23.2±6.7 | 18.6 ± 2.8 | NA | 21.4 ± 3.3 | 21.4 ± 3.3 |
L1: terminal ileum, L2: colon, L3: ileocolon, L4: upper GIT (gastrointestinal tract).